{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5b2022969cd33e762e3dc731/5b2022b191b860fa6bc329e4?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Curing Blindness With Nanotechnology","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5b2022969cd33e762e3dc731/cdfe69aa9929d969200215e22e545172.png?height=200","description":"<p>Karl Ulrich talks with Startup Challenge Semifinalist &amp; Avisi founder Rui Jing Jiang, W'18</p><p><br></p><p>Elevator Pitch, from Rui Jing: “Avisi is a medical devices company that's working on a product called VisiPlate. VisiPlate is a nanoscale aqueous implant for the drainage of intraocular fluid in glaucoma patients. Glaucoma is the second leading cause of blindness in the world, and it currently has no cure.”</p>","author_name":"Penn Wharton Entrepreneurship"}